Otsuka Pharmaceutical Factory, Inc.

Otsuka Pharmaceutical Company, Limited

Toyo Sugar Refining Co., Ltd.

Koushi Iwata

Takashi Okamura

Tetsuya Sato

Hiroshi Ishikawa

Hidetsugu Tsubouchi

Kinji Hashimoto

Yasuhide Inoue

Kazuyoshi Miyata

Tadao Shibutani

Hitoshi Ohno

Akifumi Hagi

Motoya Kikuchi

Kinue Ohguro

Satoshi Kido

Michael H Ohlmeyer

Vidyadhar Madhav Paradkar

Kurt William Saionz

Irina Neagu

Kazuhisa Doi

Daisuke Mori

Hidenori Yoshioka

Hikaru Nakata

Akiko Ishimaru

Kyo Aizawa

Yoshihisa Iida

Takashi Shimoida

Yasuhiro Kotani

An object of the present invention is to provide a protective agent for the keratoconjunctiva or a suppressive agent for a keratoconjunctival disorder having an excellent suppressive effect on a keratoconjunctival disorder. The invention relates to a protective agent for the keratoconjunctiva or a suppressive agent for a keratoconjunctival disorder containing glucosylglycerol as an active ingredient, use of glucosylglycerol for the manufacture of a pharmaceutical for protecting a keratoconjunctiva or suppressing a keratoconjunctival disorder and a method of protecting a keratoconjunctiva or suppressing a keratoconjunctival disorder comprising administering glucosylglycerol.

Protective agent for keratoconjunctiva or suppressive agent for keratoconjunctival disorder

Phenylimidazole compounds of formula (1) shown below and pharmaceutically acceptable salts thereof: Also disclosed are a pharmaceutical composition and a lipoprotein lipase activator, each containing one of the phenylimidazole compounds.

Phenylimidazole compound

The present invention provides pharmaceutical compositions containing benzene compound(s) represented by General Formula (1) below and, particularly, LPL-activating compositions for use in hyperlipidemia therapeutic and preventive agents, anti-obesity agents, and the like: wherein R, R, Rand Rare as defined in the specification.

Lipoprotein lipase-activating compositions comprising benzene derivates

The present invention provides a disinfectant that contains olanexidine in a concentration sufficient to exhibit an effective bactericidal effect, and that has hardly any side effects such as skin irritation. Specifically, the present invention provides a disinfectant containing an aqueous solution that contains olanexidine and at least an equimolar amount of gluconic acid, and substantially contains neither an acid other than gluconic acid nor a salt of the acid other than gluconic acid.

Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant

[Object] To provide a pharmaceutical product (chemotherapeutic agent) effective in the prevention and treatment of hyperlipidemia, obesity, etc. [Solving Means] A phenylimidazole compound represented by the following General Formula (1): 

Phenylimidazole compounds

Growing community of inventors

Naruto, Japan

Koushi Iwata